https://www.marketscreener.com/quote/stock/ROCHE-HOLDING-AG-9364975/news/FDA-Grants-Breakthrough-Therapy-Designation-for-Venclexta-in-Combination-with-Azacitidine-for-the-Tr-35931813/?utm_source=telegram&utm_medium=social&utm_campaign=share